Published in Ann Surg on March 01, 2006
Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J Surg (2007) 1.73
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
Biliary complications in living liver donors. Surg Today (2010) 0.93
Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford) (2009) 0.85
Case report: living donor liver transplantation for giant hepatic hemangioma using a right lobe graft without the middle hepatic vein. World J Surg Oncol (2014) 0.85
Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg (2015) 0.82
Living donor liver transplantation for end-stage liver disease with severe hepatopulmonary syndrome: report of a case. Surg Today (2011) 0.82
Interventional treatment of a biliary stricture after adult right-lobe living-donor liver transplantation with duct-to-duct anastomosis. HPB (Oxford) (2013) 0.81
Historical perspective of living donor liver transplantation. World J Gastroenterol (2008) 0.79
Living donor liver transplantation in the USA. Hepatobiliary Surg Nutr (2016) 0.79
Management of Biliary Strictures After Liver Transplantation. Gastroenterol Hepatol (N Y) (2015) 0.78
Right lobe living-donor hepatectomy-the Toronto approach, tips and tricks. Hepatobiliary Surg Nutr (2016) 0.77
Balanced approach can help initial outcomes: analysis of initial 50 cases of a new liver transplantation program in East Asia. Ann Surg Treat Res (2014) 0.75
Endoscopic management of biliary strictures after living donor liver transplantation. Clin J Gastroenterol (2017) 0.75
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med (2002) 6.64
Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33
Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl (2004) 2.65
Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation (1999) 2.61
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
A survey of liver transplantation from living adult donors in the United States. N Engl J Med (2003) 2.37
Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl (2000) 1.96
Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft. Ann Surg (2000) 1.86
Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg (2000) 1.82
Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg (2003) 1.63
Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation (2004) 1.57
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl (2001) 1.38
Duct-to-duct biliary reconstruction in living donor liver transplantation utilizing right lobe graft. Ann Surg (2002) 1.37
Increased waiting time for liver transplantation results in higher mortality. Transplantation (1997) 1.34
Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg (2004) 1.24
Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage. Transplantation (2004) 1.23
Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20
Living donor liver transplantation in adults: outcome in Europe. Liver Transpl (2000) 1.16
Biliary anastomotic complications in 400 living related liver transplantations. World J Surg (2001) 1.13
Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl (2004) 1.06
Functional venous anatomy for right-lobe grafting and techniques to optimize outflow. Liver Transpl (2001) 1.05
Right-lobe live donor liver transplantation improves survival of patients with acute liver failure. Br J Surg (2002) 1.05
Duct-to-duct biliary reconstruction in adult living-donor liver transplantation. Transplantation (2004) 1.01
Applicability of living donor liver transplantation to high-urgency patients. Transplantation (1999) 0.97
Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplant (2004) 0.95
Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes. Transplantation (2001) 0.91
Adult living donor liver transplantation. Am J Transplant (2004) 0.91
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg (2001) 0.89
Hepatic venoplasty in right lobe live donor liver transplantation. Liver Transpl (2003) 0.88
Impact of right-lobe live donor liver transplantation on patients waiting for liver transplantation. Liver Transpl (2003) 0.81
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet (2009) 10.21
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology (2002) 9.76
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res (2008) 5.46
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2002) 3.93
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med (2002) 3.84
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem (2012) 3.35
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg (2013) 3.11
miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell (2010) 2.87
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer Res (2006) 2.78
Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology (2003) 2.73
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med (2013) 2.70
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci U S A (2007) 2.56
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology (2012) 2.47
Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg (2002) 2.42
Variation in gene expression patterns in human gastric cancers. Mol Biol Cell (2003) 2.39
Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann Surg (2011) 2.38
Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res (2006) 2.32
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective. J Nucl Med (2013) 2.29
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys (2013) 2.28
Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol (2005) 2.19
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol (2011) 2.17
Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. Ann Surg (2016) 2.14
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol (2007) 2.06
Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg (2004) 2.06
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci U S A (2013) 2.05
Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg (2011) 2.05
Identification of local and circulating cancer stem cells in human liver cancer. Hepatology (2008) 2.02
Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts. Transplantation (2013) 2.00
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg (2004) 1.99
Liver resection using a saline-linked radiofrequency dissecting sealer for transection of the liver. J Am Coll Surg (2005) 1.98
Optical-CT gel-dosimetry I: basic investigations. Med Phys (2003) 1.95
Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.91
Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys (2003) 1.89
Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery (2004) 1.86
Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl (2006) 1.83
The national program for deceased organ donation in China. Transplantation (2013) 1.83
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice. Hepatology (2014) 1.80
High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg (2011) 1.79
Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg (2004) 1.79
Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg (2002) 1.77
A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys (2005) 1.76
Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol (2002) 1.75
Dilated common bile ducts mimicking choledochal cysts in ketamine abusers. Hong Kong Med J (2009) 1.73
Polypoid lesions of the gallbladder. Am J Surg (2004) 1.73
Image-guided small animal radiation research platform: calibration of treatment beam alignment. Phys Med Biol (2009) 1.72
Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys (2009) 1.70
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Liver Transpl (2007) 1.69
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology (2010) 1.66
Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol (2005) 1.66
Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin Chem (2011) 1.63
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg (2007) 1.63
Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation (2003) 1.61
Reconstruction of circumferential pharyngeal defects after tumour resection: reference or preference. J Plast Reconstr Aesthet Surg (2011) 1.61
Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol (2003) 1.59
Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis. Liver Transpl (2010) 1.59
Choledochal cysts in adults. Arch Surg (2002) 1.59
Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors. Liver Transpl (2007) 1.58